Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Makishima

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
International Journal of Cardiology|September 18, 1998
A case of primary cardiac lymphoma: utility of serum soluble interleukin-2 receptor for noninvasive diagnosisH Makishima, M Isobe, H Imamura
Leukemia|June 9, 2012
Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disordersV Visconte, H Makishima, J P Maciejewski, et al.
Bone Marrow Transplantation|November 9, 2010
Donor lymphocyte infusion for extranodal NK/T cell lymphoma, nasal type, relapsed after allogeneic hematopoietic SCTT Ito, H Makishima, H Nakazawa, et al.
Chemosphere|October 6, 1997
Analysis of oil components and hydrocarbon-utilizing microorganisms during laboratory-scale bioremediation of oil-contaminated soil of KuwaitB H Cho, H Chino, H Tsuji, et al.
Leukemia|January 17, 2012
CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitorsH Makishima, Y Sugimoto, H Szpurka, et al.
Leukemia|May 20, 2005
Significance of chemokine receptor expression in aggressive NK cell leukemiaH Makishima, T Ito, N Asano, et al.
Leukemia|January 24, 2017
Deletion of Ptpn1 induces myeloproliferative neoplasmF Jobe, B Patel, T Kuzmanovic, et al.
Leukemia|January 23, 2004
DNA microarray analysis of natural killer cell-type lymphoproliferative disease of granular lymphocytes with purified CD3-CD56+ fractionsY L Choi, H Makishima, J Ohashi, et al.
Leukemia|July 25, 2015
Runx1 repression by histone deacetylation is critical for Setbp1-induced mouse myeloid leukemia developmentB A Vishwakarma, N Nguyen, H Makishima, et al.
Leukemia|June 7, 2013
Granulocyte colony-stimulating factor receptor T595I (T618I) mutation confers ligand independence and enhanced signalingH M Mehta, T Glaubach, A Long, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
International Journal of Cardiology|September 18, 1998
A case of primary cardiac lymphoma: utility of serum soluble interleukin-2 receptor for noninvasive diagnosisH Makishima, M Isobe, H Imamura
Leukemia|June 9, 2012
Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disordersV Visconte, H Makishima, J P Maciejewski, et al.
Bone Marrow Transplantation|November 9, 2010
Donor lymphocyte infusion for extranodal NK/T cell lymphoma, nasal type, relapsed after allogeneic hematopoietic SCTT Ito, H Makishima, H Nakazawa, et al.
Chemosphere|October 6, 1997
Analysis of oil components and hydrocarbon-utilizing microorganisms during laboratory-scale bioremediation of oil-contaminated soil of KuwaitB H Cho, H Chino, H Tsuji, et al.
Leukemia|January 17, 2012
CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitorsH Makishima, Y Sugimoto, H Szpurka, et al.
Leukemia|May 20, 2005
Significance of chemokine receptor expression in aggressive NK cell leukemiaH Makishima, T Ito, N Asano, et al.
Leukemia|January 24, 2017
Deletion of Ptpn1 induces myeloproliferative neoplasmF Jobe, B Patel, T Kuzmanovic, et al.
Leukemia|January 23, 2004
DNA microarray analysis of natural killer cell-type lymphoproliferative disease of granular lymphocytes with purified CD3-CD56+ fractionsY L Choi, H Makishima, J Ohashi, et al.
Leukemia|July 25, 2015
Runx1 repression by histone deacetylation is critical for Setbp1-induced mouse myeloid leukemia developmentB A Vishwakarma, N Nguyen, H Makishima, et al.
Leukemia|June 7, 2013
Granulocyte colony-stimulating factor receptor T595I (T618I) mutation confers ligand independence and enhanced signalingH M Mehta, T Glaubach, A Long, et al.
Pageof 3